Arranat Bio MA LLC
Recipharm is a global Contract Development and Manufacturing Organization (CDMO) dedicated to operational excellence, scientific expertise, and customer connectivity. With a presence in multiple countries, Recipharm offers a wide range of pharmaceutical development, manufacturing, and device services, supporting clients from early development to commercial production. The company emphasizes responsible and sustainable operations, innovation, and collaboration to deliver reliable, high-quality pharmaceutical solutions worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Arranat Bio MA LLC
Products
Data-driven QbD and process optimisation platform
A platform that integrates material science, process science and data science to support quality-by-design, tech transfer and lifecycle management.
Data-driven QbD and process optimisation platform
A platform that integrates material science, process science and data science to support quality-by-design, tech transfer and lifecycle management.
Services
End-to-end development and GMP manufacture of biologics, ATMPs and related modalities for clinical and commercial supply.
Aseptic filling and container closure services for vials, pre-filled syringes, cartridges and ampoules, including isolator and robotic solutions.
Development, formulation and manufacture of oral solids using tableting, encapsulation, granulation, pelletisation and extrusion.
Analytical method development, validation and QC testing to support release, stability and regulatory submissions for both small molecules and biologics.
Technology transfer, pilot scale and process scale-up services to progress products from development to clinical and commercial manufacture.
Primary and secondary packaging operations across blister packs, bottles, pouches and device packaging.
End-to-end development and GMP manufacture of biologics, ATMPs and related modalities for clinical and commercial supply.
Aseptic filling and container closure services for vials, pre-filled syringes, cartridges and ampoules, including isolator and robotic solutions.
Development, formulation and manufacture of oral solids using tableting, encapsulation, granulation, pelletisation and extrusion.
Analytical method development, validation and QC testing to support release, stability and regulatory submissions for both small molecules and biologics.
Technology transfer, pilot scale and process scale-up services to progress products from development to clinical and commercial manufacture.
Primary and secondary packaging operations across blister packs, bottles, pouches and device packaging.
Expertise Areas
- Biologics and ATMP manufacturing
- Viral vector and oncolytic virus manufacturing
- mRNA and plasmid DNA production
- Lipid nanoparticle formulation for nucleic acids
Key Technologies
- Single-use bioprocess systems
- Isolator and isolated robotic filling systems
- Lyophilisation (freeze-drying)
- Blow–fill–seal (BFS)
News & Updates
Upcoming event scheduled for July 21-23, 2025.
Upcoming event scheduled for July 21-23, 2025.